首页 | 本学科首页   官方微博 | 高级检索  
     


SARC009: Phase 2 study of dasatinib in patients with previously treated,high‐grade,advanced sarcoma
Authors:Scott M. Schuetze MD  PhD  J. Kyle Wathen PhD  David R. Lucas MD  Edwin Choy MD  PhD  Brian L. Samuels MD  Arthur P. Staddon MD  Kristen N. Ganjoo MD  Margaret von Mehren MD  Warren A. Chow MD  David M. Loeb MD  PhD  Hussein A. Tawbi MD  PhD  Daniel A. Rushing MD  Shreyaskumar R. Patel MD  Dafydd G. Thomas MD  PhD  Rashmi Chugh MD  Denise K. Reinke NP  MBA  Laurence H. Baker DO
Affiliation:1. Division of Hematology/Oncology, Department of Medicine, University of Michigan, Ann Arbor, Michigan;2. Department of Biostatistics, Johnson & Johnson, New Brunswick, New Jersey;3. Anatomic Pathology, University of Michigan, Ann Arbor, Michigan;4. Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;5. Northwest Oncology, Post Falls, Idaho;6. Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania;7. Medical Oncology, Stanford Medical Institute, Stanford, California;8. Division of Medical Oncology and Hematology, Fox Chase Cancer Center, Philadelphia, Pennsylvania;9. Department of Medical Oncology and Therapeutics Research, City of Hope Medical Center, Duarte, California;10. Division of Pediatric Oncology, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland;11. Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;12. Divison of Hematology/Oncology, Department of Medicine, Indiana University, Indianapolis, Indiana;13. Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas;14. Molecular Pathology, University of Michigan, Ann Arbor, Michigan;15. Sarcoma Alliance for Research through Collaboration, Ann Arbor, Michigan
Abstract:
Keywords:adaptive  Bayesian  Choi  dasatinib  phase 2  sarcoma
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号